Sensex jumps 1,017 pts on RBI's 50-bps hike; Nifty nears 17,100; banks lead

CLOSING BELL: The benchmark indices snapped their seven-day losing streak as the RBI delivered a 50-basis point repo rate hike, and underscored the resilience of the Indian economy in his statement

SI Reporter New Delhi

Sensex jumps 1,017 pts on RBI's 50-bps hike; Nifty nears 17,100; banks lead

10:13 AM

RBI Policy LIVE: Terminal repo rate now risen by 190 bps this year

>> High Frequency indicators for Q2 indicates resilient economy
>>Rural demand picking up

10:11 AM

Sensex 30 Heatmap:: PowerGrid Corp, Reliance top gainers; Asian Paints, IT stocks weak

10:09 AM

RBI Policy LIVE: Inflation trajectory continues to be volatile

>> MPC was of the view to keep focussed on withdrawal of accomodation while supporting growth

10:08 AM

RBI Policy LIVE: Demand to continue to be firm in Q2

10:07 AM

RBI Policy LIVE : Global central banks aggressively hiking rates despite economic distress

>> Inflation continues to be high

>> Geopolitical situation affecting demand-supply scenario

>> Global central banks aggressively hiking rates at the cost of economic distress

>> Against this backdrop, Indian economy remains stable

10:05 AM

RBI Policy LIVE : Central bank raises rates by 50 bps to 5.9%

10:04 AM

RBI Policy LIVE: Das says global economy in the eye of a storm currently

10:02 AM

RBI Policy LIVE : Governor Shaktikanta Das begins his address

9:57 AM

Expert Speaks :: Nithin Kamath on India-US market correlation

One of the wasteful things that most traders do is to actively track US markets at night instead of getting a good night's sleep. Hopefully, the day-to-day divergence of our markets to the US over the last few months means traders will care lesser about the US & rest better.

9:55 AM

Nifty Bank gains marginally ahead of the RBI's policy outcome

9:48 AM

Rail Vikas Nigam adds over 1% on bagging Rs 408 crore contract from NHAI

The company has received contract for construction of 4 lane highway from Samarlakota to Achampeta Junction, from National Highways Authority of India (NHAI).

9:45 AM

Adani Green rises 2% on commissioning new wind-solar energy plant

9:42 AM

Lupin surges 4% on receiving US FDA nod for Mirabegron tablets

The pharma company has received approval from the United States Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA), Mirabegron extended-release tablets, to market in the US.